ArticlePakistan journal of medical sciences2026
Prognostic value of Cranial Ultrasound combined with Serum Neuron-Specific Enolase and Creatine Kinase-MB Isoenzyme Measurement in Neonatal Hypoxic-Ischemic Encephalopathy.
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To investigate the prognostic value of cranial ultrasound combined with serum neuron-specific enolase (NSE) and creatine kinase isoenzyme-MB (CK-MB) levels for evaluating clinical outcomes in neonates with hypoxic-ischemic encephalopathy (HIE). Methodology: A retrospective study was conducted using clinical data from 126 children with HIE admitted to Xi'an Fourth Hospital from November 2024 to December 2025 (study group). Clinical data from 126 healthy newborns were used as the control group. All the subjects underwent cranial ultrasound and NSE and CK-MB detection. Cranial ultrasound parameters and NSE and CK-MB levels were recorded, correlations among the indicators were analyzed, and the value of each indicator for predicting HIE prognosis was evaluated. Results: The peak systolic velocity (Vs) (t=18.508; P<0.001) and peak diastolic velocity (Vd) (t=22.741; P<0.001) were lower in the study group than in the control group, whereas the cerebral parenchymal echo intensity (t=26.068; P<0.001), lateral ventricle width (t=34.343; P<0.001), NSE level (t=35.618; P<0.001), and CK-MB level (t=30.276; P<0.001) were greater. Poor prognosis was associated with significantly lower Vs and Vd and greater cerebral parenchymal echo intensity, lateral ventricle width, and NSE and CK-MB levels (P<0.001). NSE and CK-MB levels in the study group were negatively correlated with Vs (r=-0.625, P<0.001; r=-0.483, P<0.001) and Vd (r=-0.568, P<0.001; r=-0.516, P<0.001) and positively correlated with cerebral parenchymal echo intensity (r=0.602, P<0.001; r=0.459, P<0.001) and lateral ventricle width (r=0.535, P<0.001; r=0.528, P<0.001). Combined detection showed the highest sensitivity and accuracy for predicting poor prognosis among the evaluated diagnostic methods. Conclusion: The combination of cranial ultrasound parameters and serum NSE and CK-MB levels is a potential prognostic indicator of HIE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.